Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ANEB Financial Statements and Analysis

NASDAQ : ANEB

Anebulo Pharmaceuticals, Inc.

$1.20
-0.03-2.44%
Open: 3:30 PM
59.92
BESG ScoreESG Rating

ANEB FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ANEB Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-12-312024-09-302024-06-302024-03-312023-12-31
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202420242024
periodQ2Q1Q4Q3Q2
revenue00000
cost of revenue00000
gross profit00000
gross profit ratio00000
research and development expenses1.221M1.315M467.706K748.339K1.063M
general and administrative expenses1.368M1.097M872.661K915.912K1.698M
selling and marketing expenses00000
selling general and administrative expenses1.368M1.097M872.661K915.912K1.698M
other expenses0002.321K-594.00
operating expenses2.588M2.412M1.34M1.664M2.76M
cost and expenses2.588M2.412M1.34M1.664M2.76M
interest income7.067K26.006K50.218K68.084K75.522K
interest expense59.696K59.697K59.696K59.696K31.838K
depreciation and amortization184.817K271.088K50.098K1.664M2.76K
ebitda-2.403M-2.141M-1.29M-1.594M-2.76M
ebitda ratio00000
operating income-2.588M-2.412M-1.34M-1.664M-2.76M
operating income ratio00000
total other income expenses net125.121K211.388K-9.602K10.709K43.09K
income before tax-2.463M-2.201M-1.35M-1.654M-2.717M
income before tax ratio00000
income tax expense000-1.664M-2.76K
net income-2.463M-2.201M-1.35M-1.654M-2.717M
net income ratio00000
eps-0.09-0.085-0.052-0.064-0.11
eps diluted-0.09-0.085-0.052-0.064-0.11
weighted average shs out27.415M25.933M25.822M25.933M25.79M
weighted average shs out dil27.415M25.933M25.822M25.933M25.79M
Graph

ANEB Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-12-312024-09-302024-06-302024-03-312023-12-31
reported currencyUSDUSDUSDUSDUSD
calendar year20252025202420242024
periodQ2Q1Q4Q3Q2
cash and cash equivalents14.998M1.404M3.094M5.147M6.645M
short term investments00000
cash and short term investments14.998M1.404M3.094M5.147M6.645M
net receivables30.756K0000
inventory00000
other current assets397.022K558.302K413.79K447.352K343.48K
total current assets15.395M1.963M3.508M5.371M6.816M
property plant equipment net00000
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets445.731K505.427K565.124K624.819K684.515K
total non current assets445.731K505.427K565.124K624.819K684.515K
other assets0001.001.00
total assets15.841M2.468M4.073M5.996M7.501M
account payables319.515K252.142K156.426K384.92K318.679K
short term debt00000
tax payables00000
deferred revenue00000
other current liabilities559.284K317.083K104.157K625.401K0
total current liabilities878.799K569.225K260.583K1.01M1.014M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities559.284K0000
total non current liabilities559.284K00625.401K694.877K
other liabilities-559.284K00-625.401K-694.877K
capital lease obligations00000
total liabilities878.799K569.225K260.583K1.01M1.014M
preferred stock00000
common stock41.086K25.934K25.934K25.934K25.934K
retained earnings-70.068M-67.604M-65.404M-64.054M-62.40M
accumulated other comprehensive income loss00000
other total stockholders equity84.989M69.477M69.19M69.013M68.862M
total stockholders equity14.962M1.899M3.813M4.985M6.487M
total equity14.962M1.899M3.813M4.985M6.487M
total liabilities and stockholders equity15.841M2.468M4.073M5.996M7.501M
minority interest00000
total investments00000
total debt00000
net debt-14.998M-1.404M-3.094M-5.147M-6.645M
Graph

ANEB Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420242023
periodQ4Q3Q2Q1Q4
deferred income tax00000
stock based compensation177.186K152.00219.00211.00223.565K
change in working capital-939.852K-55.171K652.562K-456.799K-577.231K
accounts receivables00000
inventory00000
accounts payables-228.494K66.241K-247.27K31.404K-36.357K
other working capital-711.358K-121.412K899.832K-31.404K-540.874K
other non cash items59.696K145.094K31.838K179.393K0
net cash provided by operating activities-2.053M-1.497M-1.814M-2.727M-2.849M
investments in property plant and equipment00000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00000
debt repayment00000
common stock issued00-62.354K0-68.156K
common stock repurchased00000
dividends paid00000
other financing activites00-62.000-68.156K
net cash used provided by financing activities00-62.354K0-68.156K
effect of forex changes on cash00000
net change in cash-2.053M-1.497M-1.876M-2.727M-2.917M
cash at end of period3.094M5.147M6.645M8.521M11.247M
cash at beginning of period5.147M6.645M8.521M11.247M14.165M
operating cashflow-2.053M-1.497M-1.814M-2.727M-2.849M
capital expenditure00000
free cash flow-2.053M-1.497M-1.814M-2.727M-2.849M
Graph

Frequently Asked Questions

How did Anebulo Pharmaceuticals, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ANEB generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Anebulo Pharmaceuticals, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Anebulo Pharmaceuticals, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have ANEB's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ANEB incurred $2.59M worth of Operating Expenses, while it generated -$2.59M worth of Operating Income.

How much Net Income has ANEB posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Anebulo Pharmaceuticals, Inc., the company generated -$2.46M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Anebulo Pharmaceuticals, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Anebulo Pharmaceuticals, Inc. as of the end of the last quarter was $15.00M.

What are ANEB's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ANEB had Total Net Receivables of $30.76K.

In terms of Total Assets and Current Assets, where did Anebulo Pharmaceuticals, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ANEB were $15.40M, while the Total Assets stand at $15.84M.

As of the last quarter, how much Total Debt did Anebulo Pharmaceuticals, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ANEB's debt was $0.00 at the end of the last quarter.

What were ANEB's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ANEB reported total liabilities of $878.80K.

How much did ANEB's Working Capital change over the last quarter?

Working Capital Change for ANEB was -$939.85K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ANEB generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ANEB generated -$2.05M of Cash from Operating Activities during its recently reported quarter.

What was ANEB's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ANEB reported a -$2.05M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph